These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 29011306)

  • 1. Reactions Following the Administration of the Pentavalent Compounds of Antimony: An Analysis of Cases Reported by Several Correspondents.
    Napier LE
    Ind Med Gaz; 1926 Nov; 61(11):559-561. PubMed ID: 29011306
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicity of antimony and its compounds.
    Winship KA
    Adverse Drug React Acute Poisoning Rev; 1987; 6(2):67-90. PubMed ID: 3307336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.
    Badaro R; Falcoff E; Badaro FS; Carvalho EM; Pedral-Sampaio D; Barral A; Carvalho JS; Barral-Netto M; Brandely M; Silva L
    N Engl J Med; 1990 Jan; 322(1):16-21. PubMed ID: 2104665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children.
    Apa H; Devrim İ; Bayram N; Deveci R; Demir-Özek G; Cartı ÖU
    Turk J Pediatr; 2013; 55(4):378-83. PubMed ID: 24292030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate.
    Frézard F; Demicheli C; Ferreira CS; Costa MA
    Antimicrob Agents Chemother; 2001 Mar; 45(3):913-6. PubMed ID: 11181379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy.
    Ojha RP; Cervantes D; Fischbach LA
    Clin Infect Dis; 2007 Oct; 45(8):1104; author reply 1005-6. PubMed ID: 17879933
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione.
    Yan S; Li F; Ding K; Sun H
    J Biol Inorg Chem; 2003 Jul; 8(6):689-97. PubMed ID: 12827457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpectedly high levels of antimony (III) in the pentavalent antimonial drug Glucantime: insights from a new voltammetric approach.
    Salaün P; Frézard F
    Anal Bioanal Chem; 2013 Jun; 405(15):5201-14. PubMed ID: 23612869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentavalent antimonial inhibition of the osmotic effect of oxytocin on the isolated toad bladder.
    Gagliardi AR; Veiga JP; Rosa TT; Marsden PD
    Braz J Med Biol Res; 1985; 18(4):567-71. PubMed ID: 3015305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative insensitivity of a Kenyan strain of Leishmania donovani to pentavalent antimony therapy in hamsters.
    Hanson WL; Waits VB; Hendricks LD; Hockmeyer WT; Davidson DE; Chapman WL
    J Parasitol; 1983 Apr; 69(2):446-7. PubMed ID: 6854484
    [No Abstract]   [Full Text] [Related]  

  • 11. Subacute toxicity of pentavalent antimony compounds in rats.
    alKhawajah A; Larbi EB; Jain S; al-Gindan Y; Abahussain A
    Hum Exp Toxicol; 1992 Jul; 11(4):283-8. PubMed ID: 1354978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemotherapy of visceral leishmaniasis: a pilot trial of sequential treatment with recombinant interferon-gamma and pentavalent antimony.
    Harms G; Zwingenberger K; Sandkamp B; Omena S; Pedrosa C; Richter J; Rosenkaimer F; Feldmeier H; Bienzle U
    J Interferon Res; 1993 Feb; 13(1):39-41. PubMed ID: 8454909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation/dissolution examination of antimony and antimony compounds with speciation of the transformation/dissolution solutions.
    Skeaff JM; Beaudoin R; Wang R; Joyce B
    Integr Environ Assess Manag; 2013 Jan; 9(1):98-113. PubMed ID: 22791698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
    Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
    Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis.
    Murray HW
    Acta Trop; 2005 Mar; 93(3):295-301. PubMed ID: 15716043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxic effects of the antileishmanial drug Glucantime.
    Lima MI; Arruda VO; Alves EV; de Azevedo AP; Monteiro SG; Pereira SR
    Arch Toxicol; 2010 Mar; 84(3):227-32. PubMed ID: 19911167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of pentavalent antimony.
    Singh S; Sundar S
    J Assoc Physicians India; 1994 Sep; 42(9):755. PubMed ID: 7741886
    [No Abstract]   [Full Text] [Related]  

  • 18. [Formation of pentavalent antimony minerals as a result of bacterial activity].
    Lialikova NN; Shlain LB; Trofimov VG
    Izv Akad Nauk SSSR Biol; 1974; (3):440-4. PubMed ID: 4461760
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative and environmental genotoxicity of antimony and arsenic.
    Gebel T; Christensen S; Dunkelberg H
    Anticancer Res; 1997; 17(4A):2603-7. PubMed ID: 9252688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis.
    Machado PR; Lessa H; Lessa M; Guimarães LH; Bang H; Ho JL; Carvalho EM
    Clin Infect Dis; 2007 Mar; 44(6):788-93. PubMed ID: 17304449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.